BioNexus Gene Lab Corp. (BGLC) Stock Price History
Historical prices from 2021 to 2026
Loading 10-year price history...
BGLC Historical Performance
Short-Term Returns
BGLC Stock Price Trajectory (2021–2026)
As of May 9, 2026, BioNexus Gene Lab Corp. (BGLC) trades at $2.06, representing a -22.8% return over the past year. The stock has delivered a -98.6% total return over five years (-57.2% CAGR), reflecting challenging market conditions.
The stock reached its all-time high of $322.90 on January 19, 2021. From this peak, BGLC has corrected -99.4%, currently trading 48% below its 200-day moving average, suggesting potential weakness.
When compared to Healthcare sector peers QDEL (-70.3% 1Y), CLOV (-16.8% 1Y), and RNAZ (-25.4% 1Y), BGLC has underperformed the peer group average. Compare BGLC vs QDEL →
BGLC Historical Price Data (2025–2026)
Showing 30 of 1,013 recordsLoading full history…
| Date | Open | High | Low | Close | Volume | Change % |
|---|---|---|---|---|---|---|
| 2026-05-08 | 2.15 | 2.15 | 2.05 | 2.06 | 3K | -0.96% |
| 2026-05-07 | 2.01 | 2.14 | 2.01 | 2.08 | 2K | +3.94% |
| 2026-05-06 | 2.11 | 2.11 | 2.00 | 2.00 | 4K | -1.91% |
| 2026-05-05 | 2.14 | 2.14 | 2.04 | 2.04 | 2K | 0.00% |
| 2026-05-04 | 2.09 | 2.09 | 2.04 | 2.04 | 2K | -1.86% |
| 2026-05-01 | 2.02 | 2.08 | 2.00 | 2.08 | 3K | -1.01% |
| 2026-04-30 | 2.10 | 2.10 | 2.10 | 2.10 | 471 | +1.94% |
| 2026-04-29 | 2.05 | 2.16 | 2.05 | 2.06 | 4K | -0.48% |
| 2026-04-28 | 2.08 | 2.13 | 2.07 | 2.07 | 8K | -4.61% |
| 2026-04-27 | 2.22 | 2.22 | 2.12 | 2.17 | 10K | -2.25% |
| 2026-04-24 | 2.21 | 2.22 | 2.18 | 2.22 | 4K | -0.45% |
| 2026-04-23 | 2.19 | 2.23 | 2.19 | 2.23 | 544 | +0.45% |
| 2026-04-22 | 2.26 | 2.26 | 2.21 | 2.22 | 345 | -1.77% |
| 2026-04-21 | 2.30 | 2.30 | 2.22 | 2.26 | 2K | -0.87% |
| 2026-04-20 | 2.26 | 2.28 | 2.15 | 2.28 | 4K | +3.63% |
| 2026-04-17 | 2.20 | 2.20 | 2.20 | 2.20 | 1K | +1.03% |
| 2026-04-16 | 2.19 | 2.29 | 2.18 | 2.18 | 8K | -0.11% |
| 2026-04-15 | 2.31 | 2.31 | 2.16 | 2.18 | 2K | +0.46% |
| 2026-04-14 | 2.17 | 2.17 | 2.17 | 2.17 | 1K | -3.98% |
| 2026-04-13 | 2.17 | 2.26 | 2.17 | 2.26 | 3K | +3.67% |
| 2026-04-10 | 2.30 | 2.30 | 2.15 | 2.18 | 3K | -3.08% |
| 2026-04-09 | 2.16 | 2.26 | 2.15 | 2.25 | 3K | -2.20% |
| 2026-04-08 | 2.41 | 2.41 | 2.30 | 2.30 | 3K | -0.03% |
| 2026-04-07 | 2.30 | 2.30 | 2.29 | 2.30 | 933 | +1.71% |
| 2026-04-06 | 2.21 | 2.32 | 2.21 | 2.26 | 1K | +2.44% |
| 2026-04-02 | 2.27 | 2.27 | 2.19 | 2.21 | 2K | -2.72% |
| 2026-04-01 | 2.35 | 2.35 | 2.27 | 2.27 | 3K | +6.05% |
| 2026-03-31 | 2.15 | 2.20 | 2.14 | 2.14 | 5K | -7.72% |
| 2026-03-30 | 2.33 | 2.33 | 2.20 | 2.32 | 2K | -1.22% |
| 2026-03-27 | 2.42 | 2.46 | 2.35 | 2.35 | 3K | -5.69% |
See BGLC's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs BGLC Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare BGLC vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonBGLC — Frequently Asked Questions
Quick answers to the most common questions about buying BGLC stock.
How has BGLC stock performed recently?
BGLC declined -22.8% over the past year, below its 5-year annualized CAGR of -57.2%. The stock trades below its 200-day moving average, reflecting the downtrend.
What is BGLC's all-time high price?
BioNexus Gene Lab Corp. reached $322.90 on 2021-01-19. The 52-week high is $15.60. Current 1-year return of -22.8% places the stock further from historical peaks.
Where can I download BGLC historical price data?
This page provides BGLC daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2021-2026, downloadable in CSV format.